<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">jofin</journal-id><journal-title-group><journal-title xml:lang="ru">Журнал инфектологии</journal-title><trans-title-group xml:lang="en"><trans-title>Journal Infectology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-6732</issn><publisher><publisher-name>IPO “АIDSSPbR"</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.22625/2072-6732-2014-6-2-5-11</article-id><article-id custom-type="elpub" pub-id-type="custom">jofin-230</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Оригинальные исследования</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>ОСОБЕННОСТИ КЛИНИЧЕСКОГО ТЕЧЕНИЯ ОСТРЫХ РЕСПИРАТОРНЫХ ЗАБОЛЕВАНИЙ, ВЫЗВАННЫХ АДЕНОВИРУСАМИ ЭПИДЕМИЧЕСКИ ЗНАЧИМЫХ СЕРОТИПОВ</article-title><trans-title-group xml:lang="en"><trans-title>Features of a clinical course of the acute respiratory diseases caused by adenoviruses of epidemic significant serotypes</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Львов</surname><given-names>Н. И.</given-names></name><name name-style="western" xml:lang="en"><surname>L`vov</surname><given-names>N. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доцент кафедры инфекционных болезней (с курсом медицинской паразитологии и тропических заболеваний) Военно-медицинской академии им. С.М. Кирова, к.м.н.; тел.: 8(812)292-33-57</p></bio><email xlink:type="simple">05011912@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Соминина</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Sominina</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>заведующая лабораторией биотехнологии диагностических препаратов Научно-исследовательского института гриппа, д.м.н., профессор; тел: 8(812)499-15-29</p></bio><email xlink:type="simple">anna@influenza.spb.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Жданов</surname><given-names>К. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zhdanov</surname><given-names>K. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>начальник кафедры инфекционных болезней (с курсом медицинской паразитологии и тропических заболеваний) Военно-медицинской академии им. С.М. Кирова, д.м.н., профессор; тел.: 8(812)542-92-14</p></bio><email xlink:type="simple">ZhdanovKV@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лобзин</surname><given-names>Ю. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Lobzin</surname><given-names>Yu. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>директор Научно-исследовательского института детских инфекций ФМБА России, заведующий кафедрой инфекционных болезней Северо-Западного государственного медицинского университета им. И.И. Мечникова, д.м.н., профессор, академик РАМН; тел.: 8(812)717-64-96, 8(812)717-60-51</p></bio><email xlink:type="simple">Yuriy.Lobzin@spbmapo.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Военно-медицинская академия им. С.М. Кирова, Санкт-Петербург, Россия<country>Россия</country></aff><aff xml:lang="en">Military Medical Academy named after S.M. Kirov, Saint-Petersburg, Russia<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">Научно-исследовательский институт гриппа, Санкт-Петербург, Россия<country>Россия</country></aff><aff xml:lang="en">Science Research Institute of Influenza, Saint-Petersburg, Russia<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru">Научно-исследовательский институт детских инфекций ФМБА России, Санкт-Петербург, Россия&#13;
&#13;
Северо-Западный государственный медицинский университет им. И.И. Мечникова, Санкт-Петербург, Россия<country>Россия</country></aff><aff xml:lang="en">Science Research Institute of Children`s Infections of FMBA of Russia, Science&#13;
&#13;
North-Western State Medical University named after I.I.Mechnikov, Saint-Petersburg, Russia<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>17</day><month>09</month><year>2014</year></pub-date><volume>6</volume><issue>2</issue><fpage>5</fpage><lpage>11</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Львов Н.И., Соминина А.А., Жданов К.В., Лобзин Ю.В., 2014</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="ru">Львов Н.И., Соминина А.А., Жданов К.В., Лобзин Ю.В.</copyright-holder><copyright-holder xml:lang="en">L`vov N.I., Sominina A.A., Zhdanov K.V., Lobzin Y.V.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.niidi.ru/jofin/article/view/230">https://journal.niidi.ru/jofin/article/view/230</self-uri><abstract><p>Цель – исследовать этиологическую структуру аденовирусных заболеваний у лиц молодого возраста из организованных коллективов и выявить особенности клинического течения ОРЗ, вызванных различными серотипами аденовирусов.</p><sec><title>Материалы и методы</title><p>Материалы и методы: обследовано 382 больных аденовирусными заболеваниями. Выделение вирусов из носоглоточных мазков проводили на культурах клеток Vero, HeLa, Hep-2. Типирование аденовирусов проводили в реакции нейтрализации с поликлональными субтипоспецифическими кроличьими антисыворотками. Рассчитывали среднюю (M), стандартное отклонение (SD) и частоту встречаемости (%) клинических признаков (респираторных и нереспираторных синдромов, развития пневмоний, затяжного и рецидивирующего течения). Достоверность различия (p&lt;0,05) средней, частоты встречаемости случаев в сравниваемых независимых группах оценивали по t-критерию Стьюдента и критерию φ2 (фи-квадрат) Фишера соответственно.</p></sec><sec><title>Результаты</title><p>Результаты: выделено 199 штаммов аденовирусов (52,1%). Серотипировано 183 штамма: 64 (32,2%) – 3-го серотипа, 42 (21,1%) – 4-го серотипа, 38 (19,1%) – 7-го серотипа, 15 (7,5%) – 5-го серотипа, 11 (5,5%) – 21-го серотипа, 8 (4,0%) – 1-го серотипа, 3 (1,5%) – 2-го серотипа, 2 (1,0%) – 6-го серотипа. При оценке особенностей клинического течения аденовирусных заболеваний, вызванных актуальными серотипами (3, 4, 7) аденовирусов, выявлено, что при заболеваниях, вызванных 7-м серотипом, достоверно дольше сохранялись фебрильная лихорадка (4,3±2,74 дня, p&lt;0,05), ринит (9,4±6,01 дня, p&lt;0,05), фарингит (7,9±2,87, p&lt;0,05), ларингит (7,3±2,87, p&lt;0,05) и бронхит (11,8±8,03, p&lt;0,05), достоверно чаще наблюдали тонзиллит (63,0%, φ2=12,6, p&lt;0,05), лимфаденопатию (63,0%, φ2=4,1, p&lt;0,05) и пневмонию (34,2%, φ2=3,84, p&lt;0,05).</p></sec><sec><title>Заключение</title><p>Заключение: исследование показало, что наибольшей эпидемиологической значимостью обладают аденовирусы 3-го, 4-го и 7-го серотипов, клиническими особенностями аденовирусных заболеваний, вызванных 7-м серотипом вируса, являются более частая регистрация нереспираторных синдромов и развитие пневмонии.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>The objective</title><p>The objective: To investigate etiological structure of adenoviral diseases in young people from organized groups and the clinical features of acute respiratory disease caused by different serotypes of adenovirus were identified.</p></sec><sec><title>Materials and methods</title><p>Materials and methods: A total 382 patients with adenovirusinfections were investigated. Virus isolation from nasopharyngeal swabs was carried out in cell cultures Vero, HeLa, Hep-2. Typing of adenoviruses was performed by virus neutralization test with polyclonal rabbit subtype specific sera. The average (M), standard deviation (SD) and frequency of occurrence (%) of clinical signs (respiratory and non-respiratory syndromes of pneumonia, protracted and recurrent course was calculated. Significance of the differences (p&lt;0,05) of average frequency of cases compared to independent group of patients was evaluated by Student t-test and criterion φ2 (phi – square) Fischer, respectively.</p></sec><sec><title>Results</title><p>Results: As result of investigation 199 adenovirus strains (52,1 %) were isolated. 183 strains were serotyped: 64 (32,2 %) – 3 serotype, 42 (21,1 %) – 4 serotype, 38 (19,1 %) – 7 serotype, 15 (7,5 %) – 5 serotype, 11 (5,5 %) – 21 serotype, 8 (4,0 %) – 1 serotype, 3 (1,5 %) – 2 serotype, 2 (1,0 %) – 6 serotype. In assessing the features of the clinical course of adenoviral infection caused by the most actual serotypes (3, 4, 7) of adenovirus revealed that duration of diseases caused by serotype 7 was significantly longer and remained febrile fever (4,3±2,74 days, p&lt;0,05), rhinitis (9,4±6,01 days, p&lt;0,05), pharyngitis (7,9±2,87 days, p&lt;0,05), laryngitis (7,3±2,87 days, p&lt;0,05) and bronchitis (11,8±8,03 days, p&lt;0,05), tonsillitis (63,0%, φ2=12,6, p&lt;0,05), lymphadenopathy (63,0%, φ2=4,1, p&lt;0,05), and pneumonia (34,2%, φ2=3,84, p&lt;0,05) were registered significantly more frequently.</p></sec><sec><title>Conclusion</title><p>Conclusion: The study showed that the adenoviruses of 3, 4 and 7 serotype have the greatest epidemiological significance. Clinical features of adenoviral diseases caused by 7 serotype were manifested in more frequent registration of non-respiratory syndromes and the development of pneumonia.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>аденовирусные заболевания</kwd><kwd>серотипы аденовирусов</kwd><kwd>клиническое течение</kwd><kwd>пневмония</kwd></kwd-group><kwd-group xml:lang="en"><kwd>adenoviral diseases</kwd><kwd>serotypes of adenoviruses</kwd><kwd>clinical course</kwd><kwd>pneumonia</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Lvov N.I., Lichopoenko V.P. Acute respiratory diseases: Guidelines for Infectious Diseases. Saint Petersburg: OOO «Izd-vo Foliant» Publ.; 2011 (In Russian).</mixed-citation><mixed-citation xml:lang="en">Lvov N.I., Lichopoenko V.P. Acute respiratory diseases: Guidelines for Infectious Diseases. Saint Petersburg: OOO «Izd-vo Foliant» Publ.; 2011 (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Suchovetskaja V.F. Zhurnal infektologii. 2012;4(1):36-41 (In Russian).</mixed-citation><mixed-citation xml:lang="en">Suchovetskaja V.F. Zhurnal infektologii. 2012;4(1):36-41 (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Lvov N.I. Voyenno-meditsinskiy zhurnal. 2013;8:19-23 (In Russian).</mixed-citation><mixed-citation xml:lang="en">Lvov N.I. Voyenno-meditsinskiy zhurnal. 2013;8:19-23 (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Zhdanov K.V. Vrach-provizor-patsiyent. 2011;1:8-10 (In Russian).</mixed-citation><mixed-citation xml:lang="en">Zhdanov K.V. Vrach-provizor-patsiyent. 2011;1:8-10 (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Lobzin Yu.V., Likhopoyenko V.P., Lvov N.I. Droplet infections. Saint Petersburg: IKF «Foliant» Publ.; 2000 (In Russian).</mixed-citation><mixed-citation xml:lang="en">Lobzin Yu.V., Likhopoyenko V.P., Lvov N.I. Droplet infections. Saint Petersburg: IKF «Foliant» Publ.; 2000 (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Eropkin MY, Solovskii MV, Smirnova MY, et al. Synthesis and biological activity of water-soluble polymer complex of arbidol. Pharm Chem.J. 2009;43:563-7.</mixed-citation><mixed-citation xml:lang="en">Eropkin MY, Solovskii MV, Smirnova MY, et al. Synthesis and biological activity of water-soluble polymer complex of arbidol. Pharm Chem.J. 2009;43:563-7.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Mary Miu Yee Waye, Chor Wing Sing. Anti-Viral Drugs for Human Adenoviruses. Pharmaceuticals. 2010;3:3343-54.</mixed-citation><mixed-citation xml:lang="en">Mary Miu Yee Waye, Chor Wing Sing. Anti-Viral Drugs for Human Adenoviruses. Pharmaceuticals. 2010;3:3343-54.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Leneva I.A. Mekhanizm virusspetsificheskogo deystviya preparata Arbidol [Mechanism of virus specific action of the drugs Arbidol]. Moscow (Russia): The center for chemistry of pharmaceuticals – the All-Russian research chemical and pharmaceutical institute; 2005. 303p (In Russian).</mixed-citation><mixed-citation xml:lang="en">Leneva I.A. Mekhanizm virusspetsificheskogo deystviya preparata Arbidol [Mechanism of virus specific action of the drugs Arbidol]. Moscow (Russia): The center for chemistry of pharmaceuticals – the All-Russian research chemical and pharmaceutical institute; 2005. 303p (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Medical virology. Management. Lvov D.K (eds). Moscow: OOO «Med.inform. agentstvo» Publ.; 2008 (In Russian).</mixed-citation><mixed-citation xml:lang="en">Medical virology. Management. Lvov D.K (eds). Moscow: OOO «Med.inform. agentstvo» Publ.; 2008 (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Lobzin Yu.V. Voyenno-meditsinskiy zhurnal. 2001;11: 41-50 (In Russian).</mixed-citation><mixed-citation xml:lang="en">Lobzin Yu.V. Voyenno-meditsinskiy zhurnal. 2001;11: 41-50 (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Zaytsev V.M., Liflyandskiy V.G., Marinkin V.I. Prikladnaya meditsinskaya statistika.2-e izd. Saint Petersburg: OOO «Izd-vo Foliant» Publ.; 2006 (In Russian).</mixed-citation><mixed-citation xml:lang="en">Zaytsev V.M., Liflyandskiy V.G., Marinkin V.I. Prikladnaya meditsinskaya statistika.2-e izd. Saint Petersburg: OOO «Izd-vo Foliant» Publ.; 2006 (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Erdman DD, Xu W, Gerber SI, et al. Molecular epidemiology of adenovirus type 7 in the United States, 1966-2000. Emerging Infectious Diseases. 2002 Mar.;8(3):269-77.</mixed-citation><mixed-citation xml:lang="en">Erdman DD, Xu W, Gerber SI, et al. Molecular epidemiology of adenovirus type 7 in the United States, 1966-2000. Emerging Infectious Diseases. 2002 Mar.;8(3):269-77.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Lvov N.I. Infektionnie bolezni. 2013;11(4): 65-71 (in Russian).</mixed-citation><mixed-citation xml:lang="en">Lvov N.I. Infektionnie bolezni. 2013;11(4): 65-71 (in Russian).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
